Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.265 USD | -0.46% | +6.80% | +63.37% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.37% | 299M | |
+31.87% | 694B | |
+29.39% | 593B | |
-1.67% | 371B | |
+19.38% | 331B | |
+6.73% | 290B | |
+14.20% | 239B | |
-3.19% | 209B | |
+9.98% | 209B | |
+8.24% | 169B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Transcript : Aquestive Therapeutics, Inc. - Special Call